Cardinal Health, Inc. (NYSE:CAH) was downgraded by research analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research note issued on Wednesday.
CAH has been the subject of several other reports. UBS AG restated a “neutral” rating and issued a $76.00 target price (down from $79.00) on shares of Cardinal Health in a report on Thursday, August 3rd. Credit Suisse Group restated an “outperform” rating and issued a $87.00 target price (up from $81.00) on shares of Cardinal Health in a report on Thursday, July 13th. Barclays PLC restated an “overweight” rating and issued a $82.00 target price (down from $88.00) on shares of Cardinal Health in a report on Saturday, April 22nd. William Blair cut Cardinal Health from an “outperform” rating to a “market perform” rating in a report on Wednesday, April 19th. Finally, Jefferies Group LLC began coverage on Cardinal Health in a report on Wednesday, May 17th. They issued a “hold” rating and a $77.00 target price for the company. Two investment analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $80.46.
Shares of Cardinal Health (CAH) opened at 65.16 on Wednesday. The company has a 50-day moving average price of $74.15 and a 200-day moving average price of $76.63. Cardinal Health has a 12 month low of $62.70 and a 12 month high of $84.88. The company has a market capitalization of $20.62 billion, a P/E ratio of 16.17 and a beta of 0.80.
Cardinal Health (NYSE:CAH) last issued its earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.24 by $0.07. The company had revenue of $32.97 billion during the quarter, compared to analysts’ expectations of $32.73 billion. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The firm’s quarterly revenue was up 5.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.14 EPS. On average, analysts forecast that Cardinal Health will post $4.97 EPS for the current fiscal year.
WARNING: “Cardinal Health, Inc. (CAH) Rating Lowered to Strong Sell at BidaskClub” was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.com-unik.info/2017/08/18/cardinal-health-inc-cah-rating-lowered-to-strong-sell-at-bidaskclub.html.
A number of large investors have recently modified their holdings of CAH. BlackRock Inc. increased its stake in shares of Cardinal Health by 1,041.8% in the first quarter. BlackRock Inc. now owns 21,444,922 shares of the company’s stock valued at $1,748,835,000 after buying an additional 19,566,764 shares during the period. Franklin Resources Inc. increased its position in Cardinal Health by 72.1% in the second quarter. Franklin Resources Inc. now owns 6,283,529 shares of the company’s stock worth $489,613,000 after buying an additional 2,632,836 shares during the last quarter. FMR LLC increased its position in Cardinal Health by 47.1% in the first quarter. FMR LLC now owns 5,915,289 shares of the company’s stock worth $482,391,000 after buying an additional 1,895,089 shares during the last quarter. Ameriprise Financial Inc. increased its position in Cardinal Health by 71.4% in the second quarter. Ameriprise Financial Inc. now owns 3,557,123 shares of the company’s stock worth $277,191,000 after buying an additional 1,482,285 shares during the last quarter. Finally, HealthCor Management L.P. acquired a new position in Cardinal Health during the second quarter worth approximately $84,496,000. Institutional investors own 86.41% of the company’s stock.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
What are top analysts saying about Cardinal Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cardinal Health Inc. and related companies.